claim: higher serum levels of chemokine ccl19 are associated with poor sars-cov-2 acute respiratory distress syndrome outcomes .
evidence_1: higher plasma levels of chemokine ccl19 are associated with poor sars-cov-2 acute respiratory distress syndrome (ards) outcomes.", "higher plasma levels of chemokine ccl19 are associated with poor sars-cov-2 acute respiratory distress syndrome (ards) outcomes.", "share unique inflammatory profile is associated with higher sars-cov-2 acute respiratory distress syndrome (ards) mortality.")